Invesco Global Hlth Care Innovt A USD AD

Fond

Risiko

Bærekraft

(1 av 3)

🌳

🌳

🌳

Detaljer

Pris

Totalpris (det du betaler årlig):

1,43%

Prisdetaljer

Pris for fondet:

1,93%

Plattformavgift:

0,25%

Returprovisjon:

-0,75%

Vis priser med rabatt for Akademikerne Pluss eller Tekna

Avkastning

Avkastning pr. 17.05

Siste måned:

2,0%

Siste 6 måneder:

15,4%

Hittil i år:

16,0%

Siste år:

9,6%

Siste 3 år (per år):

12,1%

Siste 5 år (per år):

12,1%

Nøkkelinfo

Morningstar-rating:

3

ISIN:

LU1775982595

Forvaltningskapital:

3 261 275 943 kr

Kategori:

Bransjefond, Helsevern

NAV/Kurs (17.05.2024):

2 115 kr

Obligasjoner:

0,0%

Kontanter:

-0,2%

Aksjer:

98,3%

Annet:

1,9%

Startdato:

07.09.2018

Fordeling

Selskap

10 største eierandeler

Eli Lilly and Co

8,6%

UnitedHealth Group Inc

7,7%

Boston Scientific Corp

5,0%

Vertex Pharmaceuticals Inc

4,1%

McKesson Corp

4,0%

Regeneron Pharmaceuticals Inc

3,7%

Merck & Co Inc

3,5%

Thermo Fisher Scientific Inc

3,4%

Stryker Corp

3,3%

Intuitive Surgical Inc

3,2%

Sektor

Helse

99,8%

Eiendom

0,3%

Region

Nord-Amerika

91,3%

Europa

8,6%

Asia

0,2%

Beskrivelse

The Fund aims to achieve long-term capital growth. The Fund seeks to achieve its objective by investing primarily in equity and equity related securities of innovative healthcare companies throughout the world. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies. The Investment Manager seeks to invest in companies that have the potential to materially improve the quality of care, access to care or cost of care through their innovative approach to products and services, use of technology, processes and business models, or management.